Rank #1438
Wayne Rothbaum
Net worth $2.9B
Biotech investing · United States
- Born
- Feb 17, 1968
- Age
- 58
- Source
- Biotech investing
- Residence
- Delray Beach, Florida
- Citizenship
- United States
- Marital status
- Married
- Children
- 3
- Education
- Master of Arts, George Washington University; Bachelor of Arts/Science, State University of New York at Binghamton
Net worth over time
Biography
- Wayne Rothbaum, who founded investment firm Quogue Capital in 2001, became a wildly successful biotech investor, deploying only his own funds.
- In 2012, Rothbaum cofounded and became the largest investor in cancer drug developer Acerta Pharma, whose drug Calquence was approved to treat forms of lymphoma and leukemia.
- In 2016, AstraZeneca paid $4 billion for 55% of Acerta Pharma and agreed to acquire the remainder of Acerta for nearly $2.5 billion paid between 2022 and 2024.
- Rothbaum is executive chair of two cancer drug firms: Kartos Therapeutics, which he cofounded in 2016, and Telios Pharma, cofounded in 2019.
- Rothbaum also led a restructuring of listed biotech firm Iovance Biotherapeutics, where he is a board member and the largest shareholder, with a 9% stake.
- Rothbaum's career was first described in the book "For Blood and Money: Billionaires, Biotech and the Quest for a Blockbuster Drug" published in 2023.
- Rothbaum donated $300 million to SUNY Binghamton--for a sports complex and scholarships--and to Ohio State University to build housing for cancer patients.
Financial assets
| Exchange | Ticker | Shares | Price |
|---|